Biovance Capital invests €4 million in Laigo Bio and co-leads its oversubscribed €17 million seed round
Lisbon, Portugal – 23 March 2026 – Biovance Capital, Portugal’s leading life sciences venture capital firm, announced today during BIO-Europe Spring in Lisbon that […]
Biovance Capital leads Series A investment in Mondego Bio together with OrbiMed and Torrey Pines
· Mondego Bio is a new Portuguese startup developing breakthrough cancer treatments. · Mondego Bio was founded by these three investors and […]
Biovance Capital is hiring an Associate
Role description The Associate role will give you the opportunity to sharpen your analytical skills by evaluating life science companies from multiple […]
Biovance Capital Joins European ESG Knowledge Project
Biovance Capital joins the reputable EU Life Sciences ESG Knowledge Project, leveraging its expertise in sustainable biotech investing to enhance industry-wide ESG […]
Biovance Capital Fund I secures investment from BIAL and reaches € 57 million
Biovance Capital Fund I receives investment from BIAL, an international pharmaceutical company based in Portugal. This investment, along with others secured since […]
Biovance debuts with €51M to lift up biotech scene in Portugal and southern Europe
Kyle LaHucikSenior Reporter Nearly a decade ago, Ricardo Perdigão Henriques’ colleagues balked at the idea of him leaving Boston to return home […]